Conducting clinical trials in China
October 26, 2010Research and Development China, Jim Wei, Medpace, clinical trials, clinical trials in Chaia, regulatory affairs
As industry pressure to conduct successful global clinical trials on time and on budget continue, tapping emerging global markets will …
Sowing into Good Ground: Using “personalized medicine” for optimal treatment value
October 26, 2010Sales and Marketing Kinapse, White paper
As demonstrating value for the “average patient” becomes ever more difficult, Health Economics and Outcomes Research leaders can use “personalised …
Novartis’ Lucentis recommended for wider EU licence
October 25, 2010Sales and Marketing CHMP, Genentech, Lucentis, Novartis, diabetic macular edema, ranibizumab
Novartis’ Lucentis has been recommended for approval in Europe to treat people suffering from vison loss due to diabetes. The …
Kinapse selected by European Medicines Agency to provide EudraVigilance data management services
October 25, 2010Business Services EMA, Kinapse
25 October, 2010 London, UK Kinapse announced today that it has been selected through a European open procurement procedure to …
Arena’s obesity treatment lorcaserin rejected by FDA
October 25, 2010Sales and Marketing Arena Pharma, Eisai, FDA, FDA complete response letter, lorcaserin, obesity
A new weight loss drug has been rejected by the FDA because of numerous concerns about side-effects and limited efficacy. …
Two thirds of pharma companies face ‘strategic crisis’
October 25, 2010Research and Development, Sales and Marketing Novartis, Pfizer, Roland Berger, generics, pharma research, pharma sales
The pharma industry is moving away from traditional in-house innovation and toward a more diversified business model, but will encounter …
Empowering patients through telehealth
October 25, 2010Sales and Marketing George MacGinnis, Henry Rivera, Michael Dillon, NHS telehealth, Whole System Demonstrators, diabetes telehealth, pa consulting, patients, telehealth
Current models of healthcare are becoming unsustainable all over the world, due to people living longer with chronic diseases, and …
FDA rejects Viropharma’s Cinryze manufacturing expansion
October 25, 2010Sales and Marketing Cinryze, FDA, FDA complete response letter, Viropharma, angioedema, pharmaceutical manufacturing
ViroPharma was dealt a blow late last week when the FDA turned down its application for additional manufacturing capacity for …
GE Healthcare’s Christopher Ehinger moves to Black Swan
October 25, 2010Black Swan Analysis, Christopher Ehinger, GE Healthcare, appointment, sales and marketing
Black Swan Analysis has appointed Christopher Ehinger as managing director.He moves to the company from GE Healthcare, where he served as oncology …
FDA warns Gilead over contamination risks at California facility
October 25, 2010Manufacturing and Production AmBisome, Cayston, FDA, Gilead, Macugen, Viread, manufacturing compliance, pharma manufacturing
Gilead Sciences has been sent a warning letter from the FDA after failing to rectify problems at a facility used to …
Digital Pharma: Pfizer, Enbrel and UK Google Adwords
October 22, 2010Medical Communications ABPI Code of Practice, Digital Pharma blog, Enbrel, Google Adwards, PMCPA, Pfizer, pharma SEO
Pfizer is using Google Adwords in the UK to promote an online eCongress for healthcare professionals interested in its arthritis …
Draftfcb Healthcare London appoints industry veterans
October 22, 2010Medical Communications Draftfcb, Draftfcb Healthcare, Jeff Daniels, Peter Hudspeth, medical communications
Draftfcb London has appointed Jeff Daniels and Peter Hudspeth as joint managing directors of its healthcare arm. “I’m excited to …
GSK cleared of unethical practices by PMCPA
October 22, 2010Medical Communications ABPI, ABPI Code of Practice, Avamys, GSK, GlaxoSmithKline, PMCPA, Rupafin, Seretide
GlaxoSmithKline has been found guilty of two transgressions of the ABPI Code of Practice in a case centring on the …
M:Communications hires Amber Bielecka
October 22, 2010Medical Communications Amber Bielecka, M:Communications, appointment, medical communications
Financial communications agency M:Communications has appointed Amber Bielecka to its international healthcare practice. She joins the agency from Citigate Dewe …
Revenue slump for GSK as Avandia sales stall
October 22, 2010Sales and Marketing Avandia, GSK, GlaxoSmithKline, UK science budget, patent box, pharma's 2010 results, pharma's Q3 results
GlaxoSmithKline has posted a third quarter loss after sales of its troubled diabetes drug Avandia and pandemic influenza products fell. …
Pfizer recalls Lipitor tablets because of ‘musty’ smell
October 22, 2010Manufacturing and Production Lipitor, Pfizer, pharma recalls, product recalls
Pfizer has recalled 191,000 bottles of its cholesterol drug Lipitor in the US after customers complained of an unusual, musty …
Lilly suspends late-stage trials of diabetes drug Protege
October 22, 2010Research and Development, Sales and Marketing MacroGenics, Protege, diabetes, lilly, type I diabetes
Eli Lilly and its partner MacroGenics have suspended phase III trials of their investigational type I diabetes drug Protege after …
Anna Protopapas to lead Takeda’s global business development unit
October 21, 2010Sales and Marketing Anna Protopapas, Japanese pharma company, Takeda, appointment, sales and marketing
Takeda has set up a new global business development unit within its US subsidiary to oversee mergers, acquisitions and other …
NHS budget ‘will have to stretch further’
October 21, 2010George Osborne, NHS, NHS Confederation, NHS funding, government, king's fund
The NHS budget has been protected from the worst of the Comprehensive Spending Review’s swingeing cuts, with a raise that …
Johnson & Johnson recalls more Tylenol
October 21, 2010Manufacturing and Production J&J, JJ, Johnson & Johnson, McNeil, Tylenol, pharma recalls, product recalls
Johnson & Johnson’s McNeil Consumer Healthcare unit has announced yet another recall affecting its Tylenol painkiller range. The latest recall …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
